Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae

Sexually Transmitted Diseases

Volumn 41, Issue 10, 2014, Pages 619-625

  Golden, Matthew R ^a,b   Barbee, Lindley A ^a,b   Kerani, Roxanne ^a,b   Dombrowski, Julia C ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; DRUG USE; GONORRHEA; HETEROSEXUALITY; HUMAN; MEN WHO HAVE SEX WITH MEN; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; ALGORITHM; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; SEXUAL BEHAVIOR; UNITED STATES;

ADMINISTRATION, ORAL; ALGORITHMS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEPHALOSPORINS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEISSERIA GONORRHOEAE; PRACTICE GUIDELINES AS TOPIC; SEXUAL BEHAVIOR; UNITED STATES;

EID: 84914151358     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000174     Document Type: Article

References (29)

1. Centers for Disease, C. and Prevention, Update to CDC's. Sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590-594.
2. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366: 485-487.
3. Ito M, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: 3185-3187.
4. Tapsall JW, Ray S, Limnios A. Characteristics and population dynamics of mosaic penA allele-containing Neisseria gonorrhoeae isolates collected in Sydney, Australia, in 2007-2008. Antimicrob Agents Chemother 2010; 54: 554-556.
5. European Centre for Disease Prevention and Control. Gonococcal Antimicrobial Susceptibility Surveillance in Europe - 2010. Stockholm: ECDC; 2012.
6. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352: 676-685.
7. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: A randomized, controlled trial. Clin Infect Dis 2005; 41: 623-629.
8. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447-1450.
9. Holtgrave DR, Pinkerton SD. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States? J Acquir Immune Defic Syndr 2007; 44: 360-363.
10. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med 2001; 21: 84-92.
11. Kerani RP Gonorrhea treatment Practices in the STD Surveillance Network (SSuN) in 2010. In 2012 National STD Prevention Conference; Minneapolis, MN; 2012
12. Gilstrap LC 3rd, Herbert WN, Cunningham FG, et al. Gonorrhea screening in male consorts of women with pelvic infection. JAMA 1977; 238: 965-966.
13. Judson FN, Wolf FC. Tracing and treating contacts of gonorrhea patients in a clinic for sexually transmitted diseases. Public Health Rep 1978; 93: 460-463.
14. Potterat JJ, Phillips L, Rothenberg RB, et al. Gonococcal pelvic inflammatory disease: Case-finding observations. Am J Obstet Gynecol 1980; 138(7 Pt 2): 1101-1104.
15. Potterat JJ, Woodhouse DE, Pratts CI, et al. Women contacts of men with gonorrhea: Case-finding yields. Sex Transm Dis 1983; 10: 29-32.
16. Lin JS, Donegan SP, Heeren TC, et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998; 178: 1707-1712.
17. Bell G, Ward H, Day S, et al. Partner notification for gonorrhoea: A comparative study with a provincial and a metropolitan UK clinic. Sex Transm Infect 1998; 74: 409-414.
18. European Centre for Disease Prevention and Control. Gonococcal Antimicrobial Susceptibility Surveillance in Europe, 2011. Stockholm: ECDC; 2013.
19. Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309: 163-170.
20. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007; 44 Suppl 3:S84-S101.
21. Cramer R, Leichliter JS, Stenger MR, et al. The legal aspects of expedited partner therapy practice: Do state laws and policies really matter? Sex Transm Dis 2013; 40: 657-662.
22. CDC. Sexually Transmitted Disease Surveillance 2012. Atlanta: CDC; 2013: 8.
23. Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 Suppl A: 109-14.
24. Waugh MA Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women. JAntimicrob Chemother 1993; 31 Suppl E: 193-8.
25. Waugh MA Azithromycin in gonorrhoea. Int J STD AIDS 1996; 7 Suppl 1: 2-4.
26. Soge OO, harger D, Schafer S, et al. Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011). Sex Transm Dis 2012; 39: 877-879.
27. Schwebke JR, Sadler R, Sutton JM, et al. Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic. Sex Transm Dis 1997; 24: 181-184.
28. Mugavero MJ, Amico KR, Horn T, et al. The state of engagement in HIV Care in the United States: From cascade to continuum to control. Clin Infect Dis 2013; 57: 1164-1171.
29. Public Health-Seattle & King County, 2011 King County Sexually Transmitted Diseases Epidemiology Report, 2012.